Earlier this year, the U.S. Food and Drug Administration released a draft guidance regarding the use of circulating tumor DNA (ctDNA) for early-stage …

The goal of liquid biopsy moved closer to reality in past weeks. Liquid biopsy is the use of a bodily fluid to collect information from a distant site…

Streck’s Cell-Free DNA BCT® was used in a groundbreaking research study detailing the early detection of cancer utilizing a blood draw. Researc…

A recent publication from the BloodPAC group seeks to standardize pre-analytical variables for liquid biopsies. Titled “Minimum Technical Data Eleme…

When choosing between glass or plastic blood collection tubes designed to maintain the cell-free DNA population, there is an often overlooked aspect w…

Researchers developing advanced methods for characterizing tumors through the analysis of circulating DNA in the bloodstream used Streck Cell-Free DNA…